*Compared to single vision lenses. Results from a prospective, randomized, double-masked, multicenter U.S. clinical trial in myopic children aged 6–12 years at initiation of treatment.
¹Essilor International, data on file (2025)
²Flitcroft DI, He M, Jonas JB, et al. IMI – Defining and Classifying Myopia: A Proposed Set of Standards for Clinical and Epidemiologic Studies. Invest Ophthalmol Vis Sci. 2019;60(3):M20–M30. doi:10.1167/iovs.18-25957.
³Flitcroft DI, Bullimore MA, Gifford KL, et al. IMI – Myopia Correction, Myopia Control and Myopia Management: Definitions and Recommended Usage. Invest Ophthalmol Vis Sci. 2025;66(6):41. doi:10.1167/iovs.66.6.41.
**H.A.L.T. is an acronym for Highly Aspherical Lenslet Target and does not imply a “halt” or “stop” of myopia progression.
† Aesthetic finish